bromopyruvic acid glutathione adduct Synthesis and anticancer activity of Pt(iv) prodrugs containing 3-bromopyruvic as an axial ligand Rewiring of mitochondrial metabolism in – 3-Bromopyruvic Acid (3-BP, β-Bromopyruvic acid,
3 Bromopyruvic Acid (3 BP, Bromopyruvic acid, NSC 11731, NSC 62343, CAS Number: 1113 59 3) Cayman Chemical The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect 3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy A schematic showing major pathways involved in 3 bromopyruvate Download Scientific Diagram Experimental and Therapeutic Medicine
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20




